REFERENCE
Dal Negro R, Piskorz P, Vives R, Guilera M, Sazonov-Kocevar V, Badia X.Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study. PharmacoEconomics 25: 665-676, No. 8, 2007
Rights and permissions
About this article
Cite this article
Montelukast reduces resource use in asthma/SAR. Pharmacoecon. Outcomes News 535, 7 (2007). https://doi.org/10.2165/00151234-200705350-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705350-00012